SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pfizer to appeal patent order on cancer drug - Sutent

13 Feb 2013 Evaluate

Pfizer, a multinational drug maker has decided to appeal against an order by the Indian Patent Office, rejecting the company’s claim for a patent over its anti-cancer drug, Sutent. Pfizer’s patent on the drug was revoked by Patent Controller, stating that the claim does not involve any inventive steps. So, the drug maker appealed in the Supreme Court. However, the apex court reinstated the patent and directed the patent office for a fresh hearing.

Pfizer manufactures prescription drugs such as Viagra, Lyrica, Viagra, Dolonex Gel, Ponstan, Citralka Liquid, and many more. Its first production unit was set up at Darukhanna in Mumbai.

Pfizer Share Price

4865.30 116.75 (2.46%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×